(Q35156759)

English

Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

based on heuristic

inferred from title

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

object named as

M G Finn

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Andrew J Gale

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Darlene J Elias

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Patricia M Averell

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Paul S Teirstein

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Mitchell Buck

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Steven D Brown

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Zinaida Polonskaya

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Andrew K Udit

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

14 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Thrombosis Research

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

128

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

e9-13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Update on heparin: what do we need to know?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Chemical modification of viruses and virus-like particles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Heparin antagonism by polyvalent display of cationic motifs on virus-like particles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Unnatural amino acid incorporation into virus-like particles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Plasma clearance of bacteriophage Qbeta particles as a function of surface charge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Anticoagulants and their reversal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Antithrombotic therapy in cardiac surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Low molecular weight protamine: a potential nontoxic heparin antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Reversal of low-molecular-weight heparin anticoagulation by synthetic protamine analogues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Protamine: a review of its toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

13 July 2018

Protamine inhibits formation of the covalent factor IXa-anti-thrombin complex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

27 September 2018

Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

27 September 2018

Adverse events after protamine administration in patients undergoing cardiopulmonary bypass: risks and predictors of under-reporting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

27 September 2018

Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153569

8 December 2018

Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21496885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/21496885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics and cardiovascular effects of a single intravenous dose of protamine in normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21496885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the quantitative action of protamine and heparin on blood coagulation. Significance in clinical and laboratory usage

1 reference

https://pubmed.ncbi.nlm.nih.gov/21496885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass

1 reference

https://pubmed.ncbi.nlm.nih.gov/21496885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polycationic calix[8]arenes able to recognize and neutralize heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21496885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.THROMRES.2011.03.021

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35156759&oldid=1953581682"